Skip to main navigation

About Us
Our Medicines
- Licensed Commercial Medicines
- Expanded Access Policy
Pipeline
PharmFilm
Our Responsibility
Investors

Events and Presentations

Events and Presentations

Presentations

Corporate Presentation – February 2026 1.8 MB

Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB

Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB

Anaphylm™ (epinephrine) Sublingual Film Oral Allergy Syndrome Challenge Study Supplemental Materials 1.5 MB

Anaphylm™ (epinephrine) Sublingual Film Pivotal Study and Type C Meeting Supplemental Materials 1.5 MB

Anaphylm™(epinephrine) Sublingual Film Pilot Clinical Studies Supplemental Materials 778.4 KB

AQST-109: EPIPHAST II Results 2 MB

AQST-109: Topline Results from Phase 1 PK Study 594.4 KB

Upcoming Events

There are no upcoming events available at this time.

Email Alerts

Investor Contact

Investor Contact

Investor FAQs

RSS Feeds

Contact Us

About Us Our Medicines Pipeline
Innovative Drug Delivery Collaborations Investors
Careers Newsroom

Images of individuals were purchased by Aquestive® Therapeutics and are intended to model real patient scenarios.

© 2019 Aquestive Therapeutics, Inc. Aquestive, and the Logo, are registered trademarks of Aquestive Therapeutics, Inc. All rights reserved.

Terms of Use Privacy Policy Compliance Sitemap